About CANSA

CANSA & SANBS Team Up for Mandela Day at Melrose Arch

CANSA & SANBS Team Up for Mandela Day at Melrose Arch

SANBS and CANSA Mandela Day3 June 2014: CANSA is teaming up with the South African National Blood Service (SANBS) to host a blood drive on Friday 18 July, at Melrose Arch, Johannesburg, in support of Nelson Mandela Day.

Elize Joubert, CANSA’s Acting CEO says “As part of our 67 minutes to the community, we taking action in a positive way by showing our support for the SANBS. We’re inspired by the late Nelson Mandela who was a prostate cancer survivor. Blood is vital for the treatment of cancer patients, as well as patients needing blood transfusions, so we encourage all to come and donate blood.”

The blood drive will be taking place at Stanlib (Ground Floor) in Melrose Arch from 10am to 4pm. Registrations take place in the Square at Melrose Arch where CANSA is hosting an exhibit on how to reduce your cancer risk.

Sini Subrayen, SANBS Public Relations Practitioner, added “We’re excited to team up with CANSA for this year’s Mandela Day. Donating blood is one the simplest ways to make a difference to the lives of others – one donation can save up to three lives. Madiba did so much for us, and we can give back by doing good and getting support for the blood drive.”

The event was a huge success with donors from all the surrounding companies in Sandton and Rosebank responding to our call for them to support the Mandela Day Blood Drive.  A total number of 188 blood donations were received.  View feedback of the day and Gallery:

To become a blood donor you must be:

  • Between the ages of 16-65 years old
  • Weigh more than 50kg
  • Have eaten a good meal before donating
  • Lead a sexually safe lifestyle

For more information, visit www.sanbs.org.za or call 0800 11 9031.

About CANSA

Read more…

Queries CANSA

Click here for contact details…

« BACK


Leave a Comment

Please note: Comment moderation is enabled and may delay your comment from showing. There is no need to resubmit your comment.
Comments will be made public, should they be approved.


Do you have a question?